Q3 2025 saw a 10% revenue increase to 21.9 MSEK, with EBITDA and net income also rising year-over-year. Improved gross margin and the Amvina acquisition drove growth, while management remains optimistic about continued expansion and profitability.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.